Cargando…
Long-Term Treatment Outcome of Progressive Mycobacterium avium Complex Pulmonary Disease
Background: Multidrug therapy is essential for preventing respiratory failure in patients with highly progressive Mycobacterium avium complex pulmonary disease (MAC-PD). However, the prognosis and long-term outcome following combination therapy is poorly understood. Methods: We retrospectively evalu...
Autores principales: | Fukushima, Kiyoharu, Kitada, Seigo, Abe, Yuko, Yamamoto, Yuji, Matsuki, Takanori, Kagawa, Hiroyuki, Oshitani, Yohei, Tsujino, Kazuyuki, Yoshimura, Kenji, Miki, Mari, Miki, Keisuke, Kida, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291046/ https://www.ncbi.nlm.nih.gov/pubmed/32370226 http://dx.doi.org/10.3390/jcm9051315 |
Ejemplares similares
-
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
por: Fukushima, Kiyoharu, et al.
Publicado: (2021) -
Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study
por: Oshitani, Yohei, et al.
Publicado: (2020) -
Managing COPD with expiratory or inspiratory pressure load training based on a prolonged expiration pattern
por: Miki, Keisuke, et al.
Publicado: (2020) -
Evaluation of Exertional Ventilatory Parameters Using Oscillometry in COPD
por: Yamamoto, Yuji, et al.
Publicado: (2020) -
Intolerance to and limitations of inspiratory muscle training in patients with advanced chronic obstructive pulmonary disease: A report of two cases
por: Yamamoto, Yuji, et al.
Publicado: (2020)